INSMED INC Weighted Average Number of Shares Outstanding, Basic and Diluted
INSMED INC (INSM) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 103.04 million shares for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-06.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2021-05-06
- INSMED INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 103.04M shares, a 14.77% increase year-over-year.
- INSMED INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-12-31 was 102.33M shares, a 14.31% increase year-over-year.
- INSMED INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-09-30 was 101.61M shares, a 13.86% increase year-over-year.
- INSMED INC weighted average number of shares outstanding, basic and diluted for the quarter ending 2020-06-30 was 96.63M shares, a 18.12% increase year-over-year.
- INSMED INC weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 97.61M shares, a 15.43% increase from fiscal 2019.
- INSMED INC weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 84.56M shares, a 9.98% increase from fiscal 2018.
- INSMED INC weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 76.89M shares, a 15.49% increase from fiscal 2017.
- INSMED INC weighted average number of shares outstanding, basic and diluted for fiscal 2017 was 66.58M shares, a 7.57% increase from fiscal 2016.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2021-03-31 | 103.04M shares 10-Q · filed 2021-05-06 | 102.69M shares derived: average of 2 quarters · filed 2021-05-06 | 102.33M shares derived: average of 3 quarters · filed 2021-05-06 | 100.91M shares derived: average of 4 quarters · filed 2021-05-06 | |||
| 2020-12-31 | 102.33M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 101.97M shares derived: average of 2 quarters · filed 2021-02-25 | 100.19M shares derived: average of 3 quarters · filed 2021-02-25 | 97.61M shares 10-K · filed 2021-02-25 | |||
| 2020-09-30 | 101.61M shares 10-Q · filed 2020-10-29 | 99.12M shares derived: average of 2 quarters · filed 2020-10-29 | 96.03M shares 10-Q · filed 2020-10-29 | 94.39M shares derived: average of 4 quarters · filed 2021-05-06 | |||
| 2020-06-30 | 96.63M shares 10-Q · filed 2020-08-06 | 93.21M shares 10-Q · filed 2020-08-06 | 91.98M shares derived: average of 3 quarters · filed 2021-05-06 | 91.29M shares derived: average of 4 quarters · filed 2021-05-06 | |||
| 2020-03-31 | 89.78M shares 10-Q · filed 2021-05-06 | 89.65M shares derived: average of 2 quarters · filed 2021-05-06 | 89.51M shares derived: average of 3 quarters · filed 2021-05-06 | 87.59M shares derived: average of 4 quarters · filed 2021-05-06 | |||
| 2019-12-31 | 89.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 89.38M shares derived: average of 2 quarters · filed 2021-02-25 | 86.86M shares derived: average of 3 quarters · filed 2021-02-25 | 84.56M shares 10-K · filed 2021-02-25 | |||
| 2019-09-30 | 89.25M shares 10-Q · filed 2020-10-29 | 85.53M shares derived: average of 2 quarters · filed 2020-10-29 | 82.91M shares 10-Q · filed 2020-10-29 | 81.42M shares derived: average of 4 quarters · filed 2021-02-25 | |||
| 2019-06-30 | 81.81M shares 10-Q · filed 2020-08-06 | 79.69M shares 10-Q · filed 2020-08-06 | 78.82M shares derived: average of 3 quarters · filed 2021-02-25 | 78.38M shares derived: average of 4 quarters · filed 2021-02-25 | |||
| 2019-03-31 | 77.54M shares 10-Q · filed 2020-04-30 | 77.32M shares derived: average of 2 quarters · filed 2021-02-25 | 77.24M shares derived: average of 3 quarters · filed 2021-02-25 | 77.12M shares derived: average of 4 quarters · filed 2021-02-25 | |||
| 2018-12-31 | 77.10M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | 77.08M shares derived: average of 2 quarters · filed 2021-02-25 | 76.98M shares derived: average of 3 quarters · filed 2021-02-25 | 76.89M shares 10-K · filed 2021-02-25 | |||
| 2018-09-30 | 77.07M shares 10-Q · filed 2019-10-30 | 76.92M shares derived: average of 2 quarters · filed 2019-10-30 | 76.82M shares 10-Q · filed 2019-10-30 | 76.79M shares derived: average of 4 quarters · filed 2020-02-25 | |||
| 2018-06-30 | 76.77M shares 10-Q · filed 2019-08-01 | 76.69M shares 10-Q · filed 2019-08-01 | 76.70M shares derived: average of 3 quarters · filed 2020-02-25 | 73.85M shares derived: average of 4 quarters · filed 2020-02-25 | |||
| 2018-03-31 | 76.62M shares 10-Q · filed 2019-05-07 | 76.66M shares derived: average of 2 quarters · filed 2020-02-25 | 72.88M shares derived: average of 3 quarters · filed 2020-02-25 | 70.21M shares derived: average of 4 quarters · filed 2020-02-25 | |||
| 2017-12-31 | 76.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | 71.01M shares derived: average of 2 quarters · filed 2020-02-25 | 68.08M shares derived: average of 3 quarters · filed 2020-02-25 | 66.58M shares 10-K · filed 2020-02-25 | |||
| 2017-09-30 | 65.31M shares 10-Q · filed 2018-10-30 | 63.76M shares derived: average of 2 quarters · filed 2018-10-30 | 63.20M shares 10-Q · filed 2018-10-30 | 62.88M shares derived: average of 4 quarters · filed 2019-02-22 | |||
| 2017-06-30 | 62.21M shares 10-Q · filed 2018-08-02 | 62.13M shares 10-Q · filed 2018-08-02 | 62.07M shares derived: average of 3 quarters · filed 2019-02-22 | 62.02M shares derived: average of 4 quarters · filed 2019-02-22 | |||
| 2017-03-31 | 62.04M shares 10-Q · filed 2018-05-02 | 62.00M shares derived: average of 2 quarters · filed 2019-02-22 | 61.96M shares derived: average of 3 quarters · filed 2019-02-22 | 61.94M shares derived: average of 4 quarters · filed 2019-02-22 | |||
| 2016-12-31 | 61.95M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | 61.92M shares derived: average of 2 quarters · filed 2019-02-22 | 61.90M shares derived: average of 3 quarters · filed 2019-02-22 | 61.89M shares 10-K · filed 2019-02-22 | |||
| 2016-09-30 | 61.88M shares 10-Q · filed 2017-11-02 | 61.88M shares derived: average of 2 quarters · filed 2017-11-02 | 61.87M shares 10-Q · filed 2017-11-02 | 61.86M shares derived: average of 4 quarters · filed 2018-02-23 | |||
| 2016-06-30 | 61.88M shares 10-Q · filed 2017-08-03 | 61.87M shares 10-Q · filed 2017-08-03 | 61.86M shares derived: average of 3 quarters · filed 2018-02-23 | 61.84M shares derived: average of 4 quarters · filed 2018-02-23 | |||
| 2016-03-31 | 61.86M shares 10-Q · filed 2017-05-03 | 61.85M shares derived: average of 2 quarters · filed 2018-02-23 | 61.82M shares derived: average of 3 quarters · filed 2018-02-23 | 61.58M shares derived: average of 4 quarters · filed 2018-02-23 | |||
| 2015-12-31 | 61.84M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | 61.81M shares derived: average of 2 quarters · filed 2018-02-23 | 61.48M shares derived: average of 3 quarters · filed 2018-02-23 | 58.63M shares 10-K · filed 2018-02-23 | |||
| 2015-09-30 | 61.77M shares 10-Q · filed 2016-11-03 | 61.30M shares derived: average of 2 quarters · filed 2016-11-03 | 57.56M shares 10-Q · filed 2016-11-03 | 55.57M shares derived: average of 4 quarters · filed 2017-02-23 | |||
| 2015-06-30 | 60.83M shares 10-Q · filed 2016-08-04 | 55.42M shares 10-Q · filed 2016-08-04 | 53.51M shares derived: average of 3 quarters · filed 2017-02-23 | 51.15M shares derived: average of 4 quarters · filed 2017-02-23 | |||
| 2015-03-31 | 49.96M shares 10-Q · filed 2016-05-05 | 49.85M shares derived: average of 2 quarters · filed 2017-02-23 | 47.92M shares derived: average of 3 quarters · filed 2017-02-23 | 45.76M shares derived: average of 4 quarters · filed 2017-02-23 | |||
| 2014-12-31 | 49.73M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | 46.91M shares derived: average of 2 quarters · filed 2017-02-23 | 44.36M shares derived: average of 3 quarters · filed 2017-02-23 | 43.09M shares 10-K · filed 2017-02-23 | |||
| 2014-09-30 | 44.08M shares 10-Q · filed 2015-11-06 | 41.68M shares derived: average of 2 quarters · filed 2015-11-06 | 40.88M shares 10-Q · filed 2015-11-06 | 40.45M shares derived: average of 4 quarters · filed 2016-02-25 | |||
| 2014-06-30 | 39.27M shares 10-Q · filed 2015-08-06 | 39.26M shares 10-Q · filed 2015-08-06 | 39.23M shares derived: average of 3 quarters · filed 2016-02-25 | 38.77M shares derived: average of 4 quarters · filed 2016-02-25 | |||
| 2014-03-31 | 39.24M shares 10-Q · filed 2015-05-07 | 39.21M shares derived: average of 2 quarters · filed 2016-02-25 | 38.61M shares derived: average of 3 quarters · filed 2016-02-25 | 36.89M shares derived: average of 4 quarters · filed 2016-02-25 | |||
| 2013-12-31 | 39.19M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 38.29M shares derived: average of 2 quarters · filed 2016-02-25 | 36.11M shares derived: average of 3 quarters · filed 2016-02-25 | 34.98M shares 10-K · filed 2016-02-25 | |||
| 2013-09-30 | 37.39M shares 10-Q · filed 2014-11-06 | 34.57M shares derived: average of 2 quarters · filed 2014-11-06 | 33.58M shares 10-Q · filed 2014-11-06 | 33.03M shares derived: average of 4 quarters · filed 2015-02-27 | |||
| 2013-06-30 | 31.75M shares 10-Q · filed 2014-08-06 | 31.65M shares 10-Q · filed 2014-08-06 | 31.58M shares derived: average of 3 quarters · filed 2015-02-27 | 29.94M shares derived: average of 4 quarters · filed 2015-02-27 | |||
| 2013-03-31 | 31.55M shares 10-Q · filed 2014-05-08 | 31.49M shares derived: average of 2 quarters · filed 2015-02-27 | 29.33M shares derived: average of 3 quarters · filed 2015-02-27 | 28.22M shares derived: average of 4 quarters · filed 2015-02-27 | |||
| 2012-12-31 | 31.43M shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27 | 28.22M shares derived: average of 2 quarters · filed 2015-02-27 | 27.11M shares derived: average of 3 quarters · filed 2015-02-27 | 26.55M shares 10-K · filed 2015-02-27 | 26.55K shares 10-K · filed 2013-03-18 | ||
| 2012-09-30 | 25.01M shares 10-Q · filed 2013-11-05 | 24.94M shares derived: average of 2 quarters · filed 2013-11-05 | 24.92M shares 10-Q · filed 2013-11-05 | 24.90M shares derived: average of 4 quarters · filed 2014-03-06 | |||
| 2012-06-30 | 24.88M shares 10-Q · filed 2013-08-06 | 24.88K shares 10-Q · filed 2012-08-07 | 24.87M shares 10-Q · filed 2013-08-06 | 24.87K shares 10-Q · filed 2012-08-07 | 24.86M shares derived: average of 3 quarters · filed 2014-03-06 | 24.85M shares derived: average of 4 quarters · filed 2014-03-06 | |
| 2012-03-31 | 24.86M shares 10-Q · filed 2013-05-07 | 24.85M shares derived: average of 2 quarters · filed 2014-03-06 | 24.85M shares derived: average of 3 quarters · filed 2014-03-06 | 18.64M shares derived: average of 4 quarters · filed 2014-03-06 | |||
| 2011-12-31 | 24.85M shares derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-06 | 24.84M shares derived: average of 2 quarters · filed 2014-03-06 | 16.57M shares derived: average of 3 quarters · filed 2014-03-06 | 23.35M shares 10-K · filed 2014-03-06 | 23.35K shares 10-K · filed 2013-03-18 | ||
| 2011-09-30 | 24.83M shares 10-Q · filed 2012-11-07 | 12.43M shares derived: average of 2 quarters · filed 2012-11-07 | 22.85M shares 10-Q · filed 2012-11-07 | ||||
| 2011-06-30 | 24.83K shares 10-Q · filed 2012-08-07 | 21.84K shares 10-Q · filed 2012-08-07 | |||||
| 2010-12-31 | 13.25K shares 10-K · filed 2013-03-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |